BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1723320)

  • 1. Hypertensive factor in different models of experimental hypertension.
    Mangiarua EI; Wright GL; Rankin GO; McCumbee WD
    Arch Int Physiol Biochim Biophys; 1991 Aug; 99(4):309-13. PubMed ID: 1723320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of dietary calcium on in vitro aortic tissue responsiveness to a hypertensive factor.
    Mangiarua EI; Wright GL; McCumbee WD
    Clin Exp Hypertens A; 1990; 12(7):1255-79. PubMed ID: 2257690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced superoxide anion formation in vascular tissues from spontaneously hypertensive and desoxycorticosterone acetate-salt hypertensive rats.
    Wu R; Millette E; Wu L; de Champlain J
    J Hypertens; 2001 Apr; 19(4):741-8. PubMed ID: 11330877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid kallikrein in spontaneously hypertensive and desoxycorticosterone acetate-salt hypertensive rats.
    Khan IM; Yamaji I; Miller DH; Margolius HS; Privitera PJ
    J Hypertens; 1993 Oct; 11(10):1039-45. PubMed ID: 8258667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance in spontaneously hypertensive rats but not in deoxycorticosterone-salt or renal vascular hypertension.
    Bursztyn M; Ben-Ishay D; Gutman A
    J Hypertens; 1992 Feb; 10(2):137-42. PubMed ID: 1313476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An antihypertensive factor in the erythrocytes of essential hypertensive subjects--effects on blood pressure and calcium uptake by vascular tissue in rats.
    Wu G; Wen Y; Chen M; Zhang S; Zhou L
    Chin Med Sci J; 1991 Sep; 6(3):136-40. PubMed ID: 1793875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.
    Schiffrin EL; Turgeon A; Deng LY
    Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma concentrations of endothelin-1 in spontaneously hypertensive rats and DOCA-salt hypertensive rats.
    Suzuki N; Miyauchi T; Tomobe Y; Matsumoto H; Goto K; Masaki T; Fujino M
    Biochem Biophys Res Commun; 1990 Mar; 167(3):941-7. PubMed ID: 2182029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphonuclear leukocytes (PMNs) functions in SHR, L-NAME- and DOCA/salt-induced hypertensive rats.
    Ohmori M; Kitoh Y; Harada K; Sugimoto K; Fujimura A
    J Hypertens; 2000 Jun; 18(6):703-7. PubMed ID: 10872554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertensive factor: calcium stimulatory activity obtained from different tissues and animal species.
    Wright GL; Huang BS; Johnson PJ; McCumbee WD
    Can J Physiol Pharmacol; 1988 Oct; 66(10):1278-81. PubMed ID: 3240410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial regulation of cyclic GMP and vascular responses in hypertension.
    Shirasaki Y; Kolm P; Nickols GA; Lee TJ
    J Pharmacol Exp Ther; 1988 Apr; 245(1):53-8. PubMed ID: 2834546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive effect of an endothelin receptor antagonist in DOCA-salt spontaneously hypertensive rats.
    Schiffrin EL; Sventek P; Li JS; Turgeon A; Reudelhuber T
    Br J Pharmacol; 1995 Aug; 115(8):1377-81. PubMed ID: 8564194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No rarefaction of cerebral arterioles in hypertensive rats.
    Werber AH; Fitch-Burke MC; Harrington DG; Shah J
    Can J Physiol Pharmacol; 1990 Apr; 68(4):476-9. PubMed ID: 2328449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal function contributes to antihypertensive effect of vasopressin in DOCA-salt but not spontaneous hypertension.
    Wang H; McNeill JR
    Am J Physiol; 1994 Nov; 267(5 Pt 2):H1842-50. PubMed ID: 7977814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal hindquarter vasoconstrictor tone, a feature common to various kinds of hypertensive rats.
    Iriuchijima J
    Jpn J Physiol; 1988; 38(4):545-8. PubMed ID: 3236573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arterial 5-hydroxytryptamine transporter function is impaired in deoxycorticosterone acetate and Nomega-nitro-L-arginine but not spontaneously hypertensive rats.
    Ni W; Lookingland K; Watts SW
    Hypertension; 2006 Jul; 48(1):134-40. PubMed ID: 16754787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different activation of vascular mitogen-activated protein kinases in spontaneously and DOCA-salt hypertensive rats.
    Kubo T; Ibusuki T; Saito E; Kambe T; Hagiwara Y
    Eur J Pharmacol; 2000 Jul; 400(2-3):231-7. PubMed ID: 10988339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arterial effects of angiotensin converting enzyme inhibition in renovascular and spontaneously hypertensive rats.
    Levy BI; Michel JB; Salzmann JL; Azizi M; Poitevin P; Camilleri JP; Safar ME
    J Hypertens Suppl; 1988 Dec; 6(3):S23-5. PubMed ID: 3225686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypotensive responses to centrally administered taurine in DOCA-salt hypertensive and spontaneously hypertensive rats.
    Inoue A; Takahashi H; Lee LC; Sasaki S; Takeda K; Yoshimura M; Nakagawa M; Ijichi H
    Jpn Circ J; 1986 Dec; 50(12):1215-23. PubMed ID: 3820530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotransmitter release, vascular responsiveness and their calcium-mediated regulation in perfused mesenteric preparation of spontaneously hypertensive rats and DOCA-salt hypertension.
    Masuyama Y; Tsuda K; Kusuyama Y; Hano T; Kuchii M; Nishio I
    J Hypertens Suppl; 1984 Dec; 2(3):S99-102. PubMed ID: 6599723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.